Psychiatric training program engagement with the pharmaceutical industry: An educational issue, not strictly an ethical one

Academic Psychiatry

Volumn 29, Issue 2, 2005, Pages 215-221

  Mohl, Paul C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CONFLICT OF INTEREST; DRUG INDUSTRY; HOSPITAL DEPARTMENT; MEDICAL EDUCATION; MEDICAL ETHICS; PRACTICE GUIDELINE; PSYCHIATRY; REVIEW; TRAINING; ARTICLE; EDUCATION; ETHICS; HUMAN; PUBLIC RELATIONS;

DRUG INDUSTRY; ETHICS, MEDICAL; ETHICS, PROFESSIONAL; HUMANS; INTERPROFESSIONAL RELATIONS; PSYCHIATRY;

EID: 26944470442     PISSN: 10429670     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ap.29.2.215     Document Type: Review

References (29)

1. Avorn J, Chen M, Hartley R: Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982; 73:4-8
2. Chew LD, O'Young TS, Hazlet TK, et al: A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med 2000; 15:478-483
3. Chren MM, Landefeld CS: Physicians' behavior and their interactions with drug companies: A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994; 271:684-689
4. Orlowski JP, Waleska L: The effects of pharmaceutical firm enticements on physician prescribing patterns, there's no such thing as a free lunch. Chest 1992; 102:270-273
5. Sandberg WS, Carlos R, Sandberg EH, et al: The effects of educational gifts from pharmaceutical firms on medical students' recall of company names or products. Acad Med 1997; 72:916-918
6. Spingarn RW, Berlin, JA, Strom BL: When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? Acad Med, 1996; 71:86-88
7. Wysong P. Time with drug reps affects prescribing: study. The Medical Post 8 Sept 1988
8. Hodges B: Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. CMAJ 1995; 153:553-559
9. American College of Physicians. Physician-industry relations: part 1: Individual physicians. Ann Intern Med 2002; 136:396-402
10. American Medical Association, Council of Ethical and Judicial Affairs. Gifts to physicians from industry. JAMA 1991; 265:501
11. American Medical Association Council on Ethical and Judicial Affairs: Code of Medical Ethics, Clarification of Gifts to Physicians from Industry. 30 Aug 2001
12. Education Council Residency Training Programme in Internal Medicine. Dept of Medicine. McMaster University, Hamilton, Ont. Development of residency program guidelines for interaction with the pharmaceutical industry. Can Med Assoc J: 1993; 149:405-408
13. Guidance Documents, www.fda.gov/cder/guidance/
14. Pharmaceutical Research and Manufacturers of America. PhRMA code on interactions with healthcare professionals. Available at: www.pharma.org/ publications/2002-04-19.391.pdf Accessed on 8/12/03
15. Whal DS: American Psychiatric Association Ethics Committee. Ethics Primer of the American Psychiatric Association. American Psychiatric Association, 2001
16. Interactions with Pharmaceutical Industry Representatives. Internal Memo of UMass Medical School Office of Psychiatric Education and Training. 6/6/02
17. Policy on Vendor Gifts. Entertainment and Sponsored Meetings and Training. UMass Memorial Health Care Policy Memo. 2/11/03
18. Angell M: Is academic medicine for sale? N Engl J Med 2000; 342:1516-1518
19. Bodenheimer T: Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342:1539-1544
20. Korn D: Conflicts of interest in biomedical research. JAMA 2000; 284:2234-2237
21. Langreth R: Drug marketing drives many clinical trials. Wall Street Journal 16 Nov 1998
22. Rennie D: Fair conduct and fair reporting of clinical trials. JAMA 1999; 282:1766-1768
23. Montgomery J, Byerly M: Pharmaceutical industry support and outcome of clinical trials presented at University of Texas Southwestern Medical Center Department of Psychiatry Grand Rounds. May 2003
24. Jibson MD: An Ethical Framework for Clinician/Industry Interactions presented at the American Association of Directors of Psychiatry Residency Training Annual Meeting. March, 2003
25. Wazana A: Physicians and pharmaceutical industry: is a gift every just a gift? JAMA 2000; 283:373-380
26. Hopper JA, Speece MW, Musial JL: Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med 1997; 12:639-642
27. McCormick BB, Tomlinson G, Brill-Edwards P, et al: Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on post-training attitudes and behavior. JAMA 2001; 286:1994-1999
28. Rosack J: Residents want education on interacting with drug industry. psychiatric news. Dec 7 2001; 36:18
29. Shaughnessy AF, Slawson DC, Bennett JH: Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med 1995; 27:581-585